[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer
Sign Up to like & getrecommendations! Published in 2025 at "Molecular Imaging and Biology"
DOI: 10.1007/s11307-025-02015-2
Abstract: This study examines the combination of FES-PET and FDG-PET as complementary imaging for detection of metastatic ILC. We retrospectively evaluated FES and FDG uptake in patients with metastatic ILC from an estrogen receptor (ER) positive… read more here.
Keywords: fdg pet; fdg; fes pet; pet ... See more keywords
P1808Routine screening practices for cardiac involvement in patients with sarcoidosis
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz748.0560
Abstract: Sarcoidosis is a multi-systemic granulomatous disease of unknown etiology. Cardiac sarcoidosis (CS) has proven to be a clinically significant cause of unexplained ventricular dysfunction, atrioventricular block (AVB) and ventricular tachyarrhythmias (VT). Studies have suggested that… read more here.
Keywords: pet fdg; sarcoidosis; cardiac involvement; involvement patients ... See more keywords
Artificial Intelligence’s Transformative Role in Illuminating Brain Function in Long COVID Patients Using PET/FDG
Sign Up to like & getrecommendations! Published in 2024 at "Brain Sciences"
DOI: 10.3390/brainsci14010073
Abstract: Cutting-edge brain imaging techniques, particularly positron emission tomography with Fluorodeoxyglucose (PET/FDG), are being used in conjunction with Artificial Intelligence (AI) to shed light on the neurological symptoms associated with Long COVID. AI, particularly deep learning… read more here.
Keywords: brain; artificial intelligence; transformative role; long covid ... See more keywords